American Society of Nephrology’s Post

ASN and JAMA will co-host a webinar to share manuscript submission do's and don’ts, rapid review considerations, and more. Space is limited. ASN welcomes: ➡️ Randomized clinical trials (Phase 2, 3, 4) ➡️ Positive or negative outcomes ➡️ Secondary data analyses of previously presented RCTs Last call to learn the best way to prepare for multiple late-breaking oral sessions and increased presentation time for high-impact research at #KidneyWk 2024. Register now: https://bit.ly/JAMAlbctLI

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics